Bepirovirsen liver biopsy study for hepatitis B
Part of Digestive system, Infections clinical trials.
This trial tests a drug called Bepirovirsen for people with chronic hepatitis B who have low levels of the virus marker (HBsAg). It aims to see if the drug can help control the infection, and involves a liver biopsy to check the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older
- You have had hepatitis B (HBsAg positive) for at least 6 months
- You are on a stable hepatitis B treatment, or have not taken any hepatitis B treatment for 6 months, or have never been treated
- Your HBsAg level is 1000 IU/mL or lower
- Your liver enzyme (ALT) is no more than 2 times the normal upper limit
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody treatment (VIR-3434) for chronic hepatitis B. It aims to see if the antibody can help your immune system control the virus, potentially allowing you to stop your current antiviral medication later.
This study tests a new medicine called AHB-137 for people with chronic hepatitis B who are HBeAg negative and currently on antiviral therapy. The goal is to see if it can help control the virus better or allow you to stop your current medication safely.
This trial studies whether pegylated interferon can help people with inactive chronic hepatitis B stay stable or improve outcomes. You may qualify if your virus levels and liver blood tests are currently low and you’ve never used antiviral treatments.
This trial tests a new drug, AHB-137, in people with chronic hepatitis B who are already on a stable antiviral treatment. It aims to see if AHB-137 can help lower the virus further or improve outcomes.
This trial tests a gene therapy called PBGENE-HBV for people with chronic hepatitis B who are already on antiviral treatment. The goal is to see if it is safe and can help control the virus.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
Hear when a new HEPATITIS B CHRONIC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.